Anesthesiology:围术期肺部超声在小儿心脏手术中的应用

2018-04-14 代东君 “罂粟花”微信号

心脏病小儿患者围术期存在呼吸功能不全的危险。本研究主要评估在小儿心脏手术中肺超声检查的作用。

背景与目的:心脏病小儿患者围术期存在呼吸功能不全的危险。本研究主要评估在小儿心脏手术中肺超声检查的作用。

方  法:本研究为随机对照试验,进行心脏手术的儿童(5岁或更年轻)随机分为对照组(n=61)和干预组(n=61)。试验组分别在手术结束时、手术后6到12小时进行肺超声检查。主要结果为术后缺氧情况,以及术后肺部并发症的发生情况。

结  果:共纳入分析的120名儿童中,试验组术后氧饱和度高于对照组(64%vs.27%; P <0.001; OR=0.210; 95%CI:0.097-0.456)。两组间术后肺部并发症无统计学差异(12%vs 3%; P = 0.093;OR=0.271; 95%CI:0.054-1.361)。试验组肺部超声评分高于对照组。对照组机械通气时间长于试验组。

结  论:围术期肺部超声检查,有助于减少心脏病小儿患者术后缺氧事件的发生并缩短机械通气时间。

原始出处:


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2051118, encodeId=9ed9205111833, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Mon Nov 05 12:07:00 CST 2018, time=2018-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275405, encodeId=b1fc12e540577, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Mon Apr 16 04:07:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588325, encodeId=ff7e158832578, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Mon Apr 16 04:07:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305722, encodeId=0e3c305e2224, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Apr 14 13:29:02 CST 2018, time=2018-04-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2051118, encodeId=9ed9205111833, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Mon Nov 05 12:07:00 CST 2018, time=2018-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275405, encodeId=b1fc12e540577, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Mon Apr 16 04:07:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588325, encodeId=ff7e158832578, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Mon Apr 16 04:07:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305722, encodeId=0e3c305e2224, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Apr 14 13:29:02 CST 2018, time=2018-04-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2051118, encodeId=9ed9205111833, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Mon Nov 05 12:07:00 CST 2018, time=2018-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275405, encodeId=b1fc12e540577, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Mon Apr 16 04:07:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588325, encodeId=ff7e158832578, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Mon Apr 16 04:07:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305722, encodeId=0e3c305e2224, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Apr 14 13:29:02 CST 2018, time=2018-04-14, status=1, ipAttribution=)]
    2018-04-16 skhzy
  4. [GetPortalCommentsPageByObjectIdResponse(id=2051118, encodeId=9ed9205111833, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Mon Nov 05 12:07:00 CST 2018, time=2018-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1275405, encodeId=b1fc12e540577, content=<a href='/topic/show?id=6a39406551e' target=_blank style='color:#2F92EE;'>#围术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40655, encryptionId=6a39406551e, topicName=围术期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Mon Apr 16 04:07:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588325, encodeId=ff7e158832578, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Mon Apr 16 04:07:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305722, encodeId=0e3c305e2224, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sat Apr 14 13:29:02 CST 2018, time=2018-04-14, status=1, ipAttribution=)]
    2018-04-14 1ddf0692m34(暂无匿称)

    学习了.长知识

    0

相关资讯

Circulation:不要气馁!运动可降低心脏遗传风险

一直以来人们都会持有这种误解:即我们无法克服自身的基因,尤其是当我们的基因指向某一高概率的疾病时,基本上我们就认命了。然而,现在越来越多的证据表明,保持一个健康的生活方式有助于人们克服不良的遗传风险。

糖尿病饮食定要加入的食物,这样吃才能吃好血糖,吃走致命并发症

近些年来,糖尿病已经成为了威胁全球公共健康的最大威胁之一,那么,糖尿病的管理就成为了值得认真探讨的话题。吃得好是糖尿病管理的重要组成部分,包括心脏健康的食物可以帮助进一步促进你糖尿病患者的健康。

Circ Res:新分子或揭示心脏病患者清晨发病原因

我们体内的生物钟一部分是由包括光暗周期在内的环境因素所决定,它控制着我们的日常生活的很多方面,例如睡眠、心律以及进食等。最近的一些研究表明身体的免疫系统也受到生物钟的调控,如影响着机体的自我修复能力以及对一天内不同时间段的伤害的响应。

Circulation:澳大利亚新研究发现卡那利氟嗪可以大幅降低2型糖尿病致命并发症

卡那利氟嗪(Invokana)是一种SGLT2抑制剂,用于治疗2型糖尿病,在针对10000人进行的临床试验中,这种药物可以降低2型糖尿病患者因心衰住院的风险。

专家警告!每天两罐苏打水心脏病风险增加两倍

苏打水的销量在持续下降,基于这一现象,近日,埃默里大学(Emory University)对含糖饮料与人口死亡率之间的联系进行了分析,揭示出每天消耗24盎司含糖饮料的人死于心脏病的风险比饮用不到1盎司的人增加两倍。

JCI:对脂肪组织的新探究揭开了糖尿病与心脏病的重要饮食诱因!

饮食诱发的糖尿病,肥胖和心脏病是全球死亡的主要原因。在为这些相关慢性疾病寻找新的治疗方法时,耶鲁的研究人员调查了一种名为ANGPTL4的蛋白质。蛋白质在调节脂蛋白代谢过程中起着重要作用,脂蛋白能够转运血液中的脂肪和脂质,并且与人类心脏疾病风险增加有关。